These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21083449)

  • 21. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children.
    Riikonen P
    Stem Cells; 1995 May; 13(3):201-5. PubMed ID: 7613488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of hematopoietic growth factors (G-CSF and GM-CSF) in the treatment of chemotherapy-induced or idiopathic bone marrow failure.
    Robak T; Krykowski E; Warzocha K; Kończalik P
    Acta Haematol Pol; 1993; 24(3):253-62. PubMed ID: 7504385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical use of hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    Tóthová E
    Vnitr Lek; 1998 Jun; 44(6):373-7. PubMed ID: 9820064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hematopoietic growth factors and anti-infective respiratory defenses].
    Gagnadoux F; Diot P; Boissinot E; Lemarié E
    Rev Mal Respir; 1997 Apr; 14(2):93-9. PubMed ID: 9198845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colony-stimulating factors in the prevention and management of infectious diseases.
    Page AV; Liles WC
    Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myeloid hemopoietic growth factors. Therapeutic possibilities and clinical experiences].
    Hansen B; Johnsen HE
    Ugeskr Laeger; 1990 Oct; 152(44):3232-7. PubMed ID: 1700524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
    Millar BC; Bell JB; Millar JL; Treleaven J; Montes A; Joffe JK; Powles RL; McElwain TJ
    Exp Hematol; 1992 Feb; 20(2):209-15. PubMed ID: 1371966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of rHu GM-CSF (Leucomax) in treatment of neutropenia during intensive chemotherapy for acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Pawelec K
    Acta Haematol Pol; 1994; 25(2):111-8. PubMed ID: 8067182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
    Ohno R
    Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
    Disis ML
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
    [No Abstract]   [Full Text] [Related]  

  • 40. G-CSF and GM-CSF in Neutropenia.
    Mehta HM; Malandra M; Corey SJ
    J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.